Venture Certified
| 혁신성장유형 | 2022-08-25 ~ 2025-08-24 | 20220826030027 | 2022-08-25 |
| 연구개발유형 | 2025-08-25 ~ 2028-08-24 | 20250819020003 | 2022-08-25 |
Revenue CAGR +337.4%
| Item | 2024 | 2023 | 2022 |
|---|---|---|---|
| Revenue | 30B | 8.8B | 1.5B |
| Operating Profit | 0.3B | 0.3B | -0.2B |
| Net Profit | 0.3B | 0.3B | -0.2B |
| Total Assets | 5.6B | 2.9B | 0.5B |
| Total Liabilities | 4.9B | 2.6B | 0.6B |
| Total Equity | 0.6B | 0.3B | -0.0B |
Debt Ratio 797.6%: Exceeds 400%, financial soundness risk
▲ 471.7%
▲ 439.1%
▲ 118.7%
▲ 255.7%
▼ 87.7%
| Name | Position | Role |
|---|---|---|
| 김두화 | 대표이사 | 대표 |
No Data – Contact
No procurement record or data not yet available| Tax Type | 부가가치세 일반과세자 |
| Status | Cert. flags confirmed (details update after further collection) |
1 Additional Data Sources
{
"address": "경북 경주시",
"ceo_name": "김두화",
"certificate": [
{
"cert_number": "20220826030027",
"changes": "",
"disclosure_date": "2022-08-26",
"first_cert_date": "2022-08-25",
"no": "1",
"type": "혁신성장유형",
"valid_period": "2022-08-25 ~ 2025-08-24"
},
{
"cert_number": "20250819020003",
"changes": "",
"disclosure_date": "2025-08-19",
"first_cert_date": "2022-08-25",
"no": "2",
"type": "연구개발유형",
"valid_period": "2025-08-25 ~ 2028-08-24"
}
],
"company_name": "(주)케이에쓰화학",
"corp_no": "230111-*******",
"financials": {
"2022": {
"capital_stock": 20000000,
"cost_of_sales": 98672000,
"current_assets": 44511000,
"current_liabilities": 35610000,
"gross_profit": 55728000,
"net_income": -22949000,
"net_income_bs": -22949000,
"non_current_assets": 8150000,
"non_current_liabilities": 20000000,
"non_operating_expenses": 21000,
"non_operating_income": 5000,
"operating_profit": -22933000,
"revenue": 154400000,
"sga_expenses": 78660000,
"total_assets": 52661000,
"total_equity": -2949000,
"total_liabilities": 55610000
},
"2023": {
"capital_stock": 20000000,
"cost_of_sales": 662752000,
"current_assets": 285490000,
"current_liabilities": 158093000,
"gross_profit": 216494000,
"net_income": 34402000,
"net_income_bs": 33496000,
"non_current_assets": 8150000,
"non_current_liabilities": 105000000,
"non_operating_expenses": 7000,
"non_operating_income": 238000,
"operating_profit": 34171000,
"revenue": 879246000,
"sga_expenses": 182322000,
"total_assets": 293640000,
"total_equity": 30547000,
"total_liabilities": 263093000
},
"2024": {
"capital_stock": 20000000,
"cost_of_sales": 2560903000,
"current_assets": 428707000,
"current_liabilities": 433344000,
"gross_profit": 393526000,
"net_income": 33988000,
"net_income_bs": 31303000,
"non_current_assets": 126487000,
"non_current_liabilities": 60000000,
"non_operating_expenses": 2347000,
"non_operating_income": 6043000,
"operating_profit": 30292000,
"revenue": 2954429000,
"sga_expenses": 363235000,
"total_assets": 555193000,
"total_equity": 61850000,
"total_liabilities": 493344000
}
},
"industry": "그 외 기타 분류 안된 화학제품 제조업",
"investment": [],
"main_products": "합성촉매제 제조/산화제,환원제 도소매/연구개발",
"phone": "010-4801-****",
"years": [
2024,
2023,
2022
]
}Data Quality: 8/10 | Primary Source: Venture System | Section Coverage: 7/8
| Section | Source: | Status |
|---|---|---|
| Basic Info | Public Data | Collected |
| Financial Statements | Venture System | Collected |
| Investment Metrics | Venture System | Collected |
| Officers | Public Data | Collected |
| Employment | Not Collected | Not Collected |
| Certifications | Public Data | Collected |
| Patents | KIPRIS | Collected |
| Procurement | G2B Procurement | Collected |
| API | Collected | Status |
|---|---|---|
| G2B Procurement | 2026-02-25 | Collected |
| Employment Insurance | 2026-02-25 | Collected |
| KIPRIS Patents | 2026-02-25 | Collected |
| HomeTax Business | 2026-02-25 | Collected |
| Venture System Detail | 2026-02-25 | Collected |